BIOMAT Database Logo BIOMAT Database Logo

Inhibitor-1 is not required for the activation of glycogen synthase by insulin in skeletal muscle. 1999

A G Scrimgeour, and P B Allen, and A A Fienberg, and P Greengard, and J C Lawrence
Department of Pharmacology, University of Virginia School of Medicine, Charlottesville, Virginia 22908, USA.

Glycogen synthase is an excellent in vitro substrate for protein phosphatase-1 (PP1), which is potently inhibited by the phosphorylated forms of DARPP-32 (dopamine- and cAMP-regulated phosphoprotein, M(r) = 32,000) and Inhibitor-1. To test the hypothesis that the activation of glycogen synthase by insulin is due to a decrease in the inhibition of PP1 by the phosphatase inhibitors, we have investigated the effects of insulin on glycogen synthesis in skeletal muscles from wild-type mice and mice lacking Inhibitor-1 and DARPP-32 as a result of targeted disruption of the genes encoding the two proteins. Insulin increased glycogen synthase activity and the synthesis of glycogen to the same extent in wild-type and knockout mice, indicating that neither Inhibitor-1 nor DARPP-32 is required for the full stimulatory effects of insulin on glycogen synthase and glycogen synthesis in skeletal muscle.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D010750 Phosphoproteins Phosphoprotein
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006006 Glycogen Synthase An enzyme that catalyzes the transfer of D-glucose from UDPglucose into 1,4-alpha-D-glucosyl chains. EC 2.4.1.11. Glycogen (Starch) Synthase,Glycogen Synthetase,Glycogen Synthase I,Synthase D,Synthase I,UDP-Glucose Glycogen Glucosyl Transferase,Synthase, Glycogen,Synthetase, Glycogen,UDP Glucose Glycogen Glucosyl Transferase
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

A G Scrimgeour, and P B Allen, and A A Fienberg, and P Greengard, and J C Lawrence
Glycogen synthase in diabetic rat skeletal muscle: activation by insulin.
October 1982, Molecular and cellular biochemistry,
A G Scrimgeour, and P B Allen, and A A Fienberg, and P Greengard, and J C Lawrence
Glycogen synthase: activation by insulin and effect of transgenic overexpression in skeletal muscle.
February 1997, Biochemical Society transactions,
A G Scrimgeour, and P B Allen, and A A Fienberg, and P Greengard, and J C Lawrence
Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy.
November 2011, American journal of physiology. Cell physiology,
A G Scrimgeour, and P B Allen, and A A Fienberg, and P Greengard, and J C Lawrence
Effect of glucose phosphorylation on the activation by insulin of skeletal muscle glycogen synthase.
May 1995, Biochimica et biophysica acta,
A G Scrimgeour, and P B Allen, and A A Fienberg, and P Greengard, and J C Lawrence
Impaired skeletal muscle glycogen synthase activation by insulin in the Goto-Kakizaki (G/K) rat.
September 1994, Diabetologia,
A G Scrimgeour, and P B Allen, and A A Fienberg, and P Greengard, and J C Lawrence
Jun N-terminal kinase mediates activation of skeletal muscle glycogen synthase by insulin in vivo.
November 1996, The Journal of biological chemistry,
A G Scrimgeour, and P B Allen, and A A Fienberg, and P Greengard, and J C Lawrence
Activation of glycogen synthase in skeletal muscle: effects of insulin during late pregnancy.
February 1997, Biochemical Society transactions,
A G Scrimgeour, and P B Allen, and A A Fienberg, and P Greengard, and J C Lawrence
Insulin-mediated activation of glycogen synthase in isolated skeletal muscle: role of mitochondrial respiration.
May 1995, Biochimica et biophysica acta,
A G Scrimgeour, and P B Allen, and A A Fienberg, and P Greengard, and J C Lawrence
Exercise-enhanced activation of glycogen synthase in human skeletal muscle.
June 1990, The American journal of physiology,
A G Scrimgeour, and P B Allen, and A A Fienberg, and P Greengard, and J C Lawrence
Impaired activation of skeletal muscle glycogen synthase in non-insulin-dependent diabetes mellitus is unrelated to the degree of obesity.
March 1991, Metabolism: clinical and experimental,
Copied contents to your clipboard!